Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80


Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size.

Leiting JL, Bergquist JR, Hernandez MC, Merrell KW, Folpe AL, Robinson SI, Nagorney DM, Truty MJ, Grotz TE.

Sarcoma. 2018 Dec 5;2018:7972389. doi: 10.1155/2018/7972389. eCollection 2018.


Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.

Cosper PF, Olsen J, DeWees T, Van Tine BA, Hawkins W, Michalski J, Zoberi I.

Radiat Oncol. 2017 Dec 8;12(1):198. doi: 10.1186/s13014-017-0920-y.


Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.

Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, Karakousis GC.

Surg Oncol. 2017 Jun;26(2):117-124. doi: 10.1016/j.suronc.2017.01.008. Epub 2017 Feb 2. Review.


Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.

Nathan H, Raut CP, Thornton K, Herman JM, Ahuja N, Schulick RD, Choti MA, Pawlik TM.

Ann Surg. 2009 Dec;250(6):970-6. doi: 10.1097/SLA.0b013e3181b25183.


An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?

Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL.

Am J Clin Oncol. 2019 Feb;42(2):160-165. doi: 10.1097/COC.0000000000000486.


Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.

Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK.

Eur J Surg Oncol. 2015 Oct;41(10):1386-92. doi: 10.1016/j.ejso.2015.07.014. Epub 2015 Jul 29.


The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas.

Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Keenan JE, Stinnett SS, Kirsch DG, Tyler DS, Blazer DG 3rd.

Surg Oncol. 2014 Sep;23(3):155-60. doi: 10.1016/j.suronc.2014.07.001. Epub 2014 Jul 23. Review.


Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas.

Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd.

Ann Surg. 2015 Jul;262(1):163-70. doi: 10.1097/SLA.0000000000000840.


Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma.

Lane WO, Cramer CK, Nussbaum DP, Speicher PJ, Gulack BC, Czito BG, Kirsch DG, Tyler DS, Blazer DG 3rd.

J Surg Oncol. 2015 Sep;112(4):352-8. doi: 10.1002/jso.23996. Epub 2015 Aug 4.


The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.

Stahl JM, Corso CD, Park HS, An Y, Rutter CE, Han D, Roberts KB.

Eur J Surg Oncol. 2017 Jan;43(1):168-174. doi: 10.1016/j.ejso.2016.05.031. Epub 2016 Jun 10.


Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.

Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, Guadagnolo BA.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):158-65. doi: 10.1016/j.ijrobp.2015.04.047. Epub 2015 May 2.


Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.

Nathenson MJ, Barysauskas CM, Nathenson RA, Regine WF, Hanna N, Sausville E.

World J Surg Oncol. 2018 Oct 11;16(1):203. doi: 10.1186/s12957-018-1505-4.


Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

Posch F, Leitner L, Bergovec M, Bezan A, Stotz M, Gerger A, Pichler M, Stöger H, Liegl-Atzwanger B, Leithner A, Szkandera J.

Clin Orthop Relat Res. 2017 May;475(5):1427-1435. doi: 10.1007/s11999-017-5232-x. Epub 2017 Jan 12.


Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis.

Choi AH, Barnholtz-Sloan JS, Kim JA.

Ann Oncol. 2012 Sep;23(9):2449-57. doi: 10.1093/annonc/mdr616. Epub 2012 Feb 9.


A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.

Bremjit PJ, Jones RL, Chai X, Kane G, Rodler ET, Loggers ET, Pollack SM, Pillarisetty VG, Mann GN.

Ann Surg Oncol. 2014 Jul;21(7):2150-8. doi: 10.1245/s10434-014-3616-7. Epub 2014 Mar 11.


Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient.

Zhou Z, McDade TP, Simons JP, Ng SC, Lambert LA, Whalen GF, Shah SA, Tseng JF.

Arch Surg. 2010 May;145(5):426-31. doi: 10.1001/archsurg.2010.70.


Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.

Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE.

Cancer. 2017 May 15;123(6):967-976. doi: 10.1002/cncr.30439. Epub 2016 Nov 7.


Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.

Garcia-Ortega DY, Villa-Zepeda O, Martinez-Said H, Cuellar-Hübbe M, Luna-Ortiz K.

Int J Surg. 2016 Aug;32:45-9. doi: 10.1016/j.ijsu.2016.06.001. Epub 2016 Jun 4.


Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma.

Stucky CC, Wasif N, Ashman JB, Pockaj BA, Gunderson LL, Gray RJ.

J Surg Oncol. 2014 Jun;109(8):798-803. doi: 10.1002/jso.23576. Epub 2014 Feb 21.


Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.

Sharpe SM, In H, Winchester DJ, Talamonti MS, Baker MS.

J Gastrointest Surg. 2015 Jan;19(1):117-23; discussion 123. doi: 10.1007/s11605-014-2615-0. Epub 2014 Aug 26.


Supplemental Content

Support Center